Skip to main content
SpringerLink
Log in

Perinatal/Neonatal Case Presentation

Neonatal withdrawal syndrome following in utero exposure to paroxetine, clonazepam and olanzapine

  • Perinatal/Neonatal Case Presentation
  • Published:
Journal of Perinatology Submit manuscript

Abstract

We describe a full-term infant with failed respiratory effort and decerebrate posturing following in utero exposure to paroxetine. All signs and symptoms associated with the paroxetine exposure were resolved by the second day of life. Upon discharge, the infant revealed a normal neurodevelopmental examination.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Eberhard-Gran M, Eskild A, Opjordsmoen S . Treating mood disorders during pregnancy: safety considerations. Drug Saf 2005; 28(8): 695–706.

    Article  CAS  Google Scholar 

  2. FDA Public Health Advisory. Paroxetine. December 8, 2005 [cited January 12, 2007]. Available from http://www.fda.gov.

  3. Laine K, Heikkinen T, Ekblad U, Kero P . Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry 2003; 60: 720–726.

    Article  CAS  Google Scholar 

  4. Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 2005; 293: 2372–2383.

    Article  CAS  Google Scholar 

  5. Thormahlen G . Paroxetine use during pregnancy: is it safe? Ann Pharmacother 2006; 40: 1834–1837.

    Article  CAS  Google Scholar 

  6. DOA Specificity Table. Tricyclic Antidepressants.. Biosite Incorporated: San Diego, CA, March 2006.

  7. Gentile S . Clinical utilization of atypical antipsychotics in pregnancy and lactation. Ann Pharmacother 2004; 38: 1265–1271.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy, Centennial Medical Center, Nashville, TN, USA

    K L Murray & K M Miller

  2. Mid-Tennessee Neonatology Associates, Centennial Medical Center, Nashville, TN, USA

    D L Pearson

Authors
  1. K L Murray
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K M Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D L Pearson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K L Murray.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Murray, K., Miller, K. & Pearson, D. Neonatal withdrawal syndrome following in utero exposure to paroxetine, clonazepam and olanzapine. J Perinatol 27, 517–518 (2007). https://doi.org/10.1038/sj.jp.7211772

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7211772

  • Springer Nature America, Inc.

Keywords

This article is cited by

Search

Navigation